Friday - June 19, 2026

Category Archives: Science

Charcot Marie Tooth Pipeline Shows Strong Momentum as 13+ Pharma Companies in the Race | DelveInsight

DelveInsight’s, “Charcot Marie Tooth Disease Pipeline Insight, 2026” report provides comprehensive insights about 13+ companies and 15+ pipeline drugs in Charcot Marie Tooth Disease pipeline landscape. It covers the Charcot Marie Tooth pipeline drug profiles, including clinical and nonclinical stage … Continue reading →

Hemophagocytic Lymphohistiocytosis Market Size is Expected to Witness Robust Growth by 2036 Driven by Emerging Targeted Therapies and Expanding Treatment Landscape | DelveInsight

The Hemophagocytic Lymphohistiocytosis (HLH) Market is anticipated to experience substantial growth through 2036, driven by increasing disease recognition, improving diagnostic rates, growing adoption of targeted therapies, and the expected launch of novel pipeline candidates. The emergence of therapies such as … Continue reading →

Myelofibrosis Market is Projected to Grow Significantly by 2036 Owing to the Launch of Novel Disease-Modifying Therapies | DelveInsight

The market dynamics for Myelofibrosis are witnessing substantial growth driven by the increasing prevalence of the disease, rising adoption of JAK inhibitors, growing awareness of myeloproliferative neoplasms, and the development of innovative disease-modifying therapies. Additionally, the launch of emerging therapies … Continue reading →

Chronic Rhinosinusitis with Nasal Polyps Pipeline Appears Robust With 8+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s “Chronic Rhinosinusitis with Nasal Polyps Pipeline Insight 2026” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in the Chronic Rhinosinusitis with Nasal Polyps pipeline landscape. It covers the Chronic Rhinosinusitis with Nasal Polyps Pipeline drug profiles, … Continue reading →

Crohns’ Disease Pipeline Appears Robust With 90+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s, “Crohn’s Disease Pipeline Insight 2026” report provides comprehensive insights about 90+ companies and 90+ pipeline drugs in Crohn’s Disease pipeline landscape. It covers the Crohn’s Disease pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Myotonic Dystrophy Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s, “Myotonic Dystrophy Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Myotonic Dystrophy pipeline landscape. It covers the Myotonic Dystrophy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Myocardial Infarction Pipeline Appears Robust With 30+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s, “Myocardial Infarction Pipeline Insight 2026” report provides comprehensive insights about 30+ companies and 40+ pipeline drugs in Myocardial Infarction pipeline landscape. It covers the Myocardial Infarction pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Nontuberculous Mycobacterial Infections Therapeutics Market Size (US) was ~USD 360 Million in 2023 and It is projected to grow at a significant CAGR by 2034

DelveInsight’s “Nontuberculous Mycobacterial Infections Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of NTM Infections, historical and forecasted epidemiology, as well as the NTM Infections market trends in the United States. Discover Key Insights into … Continue reading →